Endothelial-mediated regulation of cerebral microcirculation

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 11, 2006, Pages 133-144

  Mccarron, R M ^a,b   Chen, Y ^a   Tomori, T ^a   Strasser, A ^a   Mechoulam, R ^d   Shohami, E ^d   Spatz, Maria ^a,c  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Uniformed Services University   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

2 AG; Brain endothelium; Endothelin; Ischemia reperfusion; Nitric oxide

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 ARACHIDONOYLGLYCEROL; APAMIN; CAPSAZEPINE; CHARYBDOTOXIN; CLAZOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOCANNABINOID; ENDOTHELIN 1; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; QUININE; RIMONABANT; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; BLOOD BRAIN BARRIER; BLOOD VESSEL TONE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; BRAIN PERFUSION; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL FUNCTION; CEREBROSPINAL FLUID; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; GERBIL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REPERFUSION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACTINS; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CALCIUM; CELLS, CULTURED; CYTOSKELETON; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GERBILLINAE; GLYCERIDES; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NITRIC OXIDE; REPERFUSION INJURY;

EID: 34147137204     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Rapport SI. Blood-Brain Barrier in Physiology and Medicine. New York, Raven, 1976.
2. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictive peptide produced by endothelial cells. Nature 1988; 332: 411-415.
3. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
4. Masaki T. Endothelin in vascular biology. Ann NY Acad Sci 1994; 714: 101-108.
5. Gellai M, De Wolf R, Fletcher T, Nambi P. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of the nitric oxide. Pharmacology 1997; 55: 299-308.
6. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
7. Haynes WG and Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 1998; 16: 1081-1098.
8. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994; 14: 175-192.
9. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin-1 induced reduction in cerebral blood flow: dose dependency, time course and neuropathological consequences. J Cereb Blood Flow Metab 1993; 13: 276-284.
10. Barone FC, Globus MY, Price WJ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14: 337-342.
11. Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur J Pharmacol 1998; 362: R1-R3.
12. Hunley TE, Iwasaki S, Homma T, Kon V. Nitric oxide and endothelin in pathophysiological settings. Pediatr Nephrol 1995; 9: 235-424.
13. Dawson DA, Sugano H, McCarron RM, Hallenbeck JM, Spatz M. Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem Res 1999; 24: 1499-1505.
14. Dawson DA. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 1994; 6: 299-324.
15. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21: 2-14.
16. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001; 280: C719-C741.
17. Shohami E, Beit-Yannai E, Horowitz M, Kohen R. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 1997; 17: 1007-1019.
18. Randall MD, Kendall DA. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 1998; 19: 55-58.
19. McCarron RM, Shohami E, Panikashvili D, et al Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG). Acta Neurochir Suppl 2003; 86: 271-275.
20. Spatz M, Kawai N, Merkel N, Bembry J, McCarron RM. Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol Cell Physiol 1997; 272: C231-C239.
21. Chen Y, McCarron RM, Bembry J, et al. Nitric oxide modulates ET-1-induced Ca2+ mobilization and cytoskeletal F-actin filaments in human cerebromicrovascular endothelial cells. J Cereb Blood Flow Metab 1999; 19: 133-138.
22. Stanimirovic D, Yamamoto T, Uematsu S, Spatz M. Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J Neurochem 1994; 62: 592-601.
23. Chen Y, McCarron RM, Ohara Y, et al. Mechoulam R, and Spatz M. Human brain capillary endothelium 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ Res 2000; 87: 323-327.
24. Chen Y, McCarron RM, Golech S, et al. ET-1- and NO-mediated signal transduction pathway in human brain capillary endothelial cells. Am J Physiol Cell Physiol 2003; 284: C243-249.
25. Panikashvili D, Shein NA, Mechoulam R, et al. The endocannabinoid 2-AG protects the bloodbrain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2006; 22: 257-264.
26. Golech SA, McCarron RM, Chen Y, et al. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res 2004; 132: 87-92.
27. Suzuki R, Masaoka H, Hirata Y, Marumo F, lsotani E, Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1992; 77: 96-100.
28. Ehrenreich H, Lange M, Near KA, et al. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-hr urine of patients with subarachnoid hemorrhage. Res Exp Med 1992; 192:257-268.
29. Prado R, Watson BD, Webster P. Effects of nitric oxide synthase inhibition on cerebral blood flow following bilateral carotid artery occlusion and recirculation in the rat. J Cereb Blood Flow Metab 1993; 13: 720-723.
30. Sancesario G, Lannone M, Morello M, Nitisco G, Bernardi G. Nitric oxide inhibition aggravates ischemic damage of hippocampal but not of NADPH neurons in gerbils. Stroke 1994; 25: 436-443.
31. Spatz M, Stanimirovic D, Strasser A, McCarron RM. Nitro-L-arginine augments the endothelin-I content of cerebrospinal fluid induced by cerebral ischemia. Brain Res 1995; 684: 99-102.
32. Spatz M, Yasuma Y, Strasser A, McCarron RM. Cerebral postischemic hypoperfusion is mediated by ETA receptors. Brain Res 1996; 726: 242-246.
33. Cornwell TL, Lincoln TM. Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 1989; 264: 1146-1155.
34. Rasmussen H. Cellular calcium metabolism. Ann Intern Med 1983; 98: 809-816.
35. Reinhard M, Halbrugge M, Scheer U, Wiegand C, Jockusch BM, Walter U. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J 1992; 11: 2063-2070.
36. Farre AL, Riesco A, Moliz M, Egido J, Casado S, Hernando L, Caramelo C. Inhibition by Larginine of the endothelinmediated increase in cytosolic calcium in human neutrophils. Biochem Biophys Res Commun 1991; 178: 884-891.
37. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP. Circulation 1995; 92: 3337-3349.
38. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396: 269-272.